Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Increased Myeloperoxidase in the Placenta and Circulation of Women With Preeclampsia

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Publication Information:
      Hagerstown, MD; Philadelphia, PA: Lippincott, 2008.
    • Publication Date:
      2008
    • Original Material:
      INIST-CNRS
    • Abstract:
      -Myeloperoxidase (MPO) is a hemoprotein normally released from activated monocytes and neutrophils. Traditionally viewed as a microbicidal enzyme, MPO also induces low-density lipoprotein oxidation, activates metalloproteinases, and oxidatively consumes endothelium-derived NO. The elevated plasma MPO level is a risk factor for myocardial events in patients with coronary artery disease. Patients with preeclampsia display evidence of the inflammation and endothelial dysfunction associated with oxidative stress in the circulation, vasculature, and placenta. We hypothesized that MPO levels in the circulation and placental extracts from women with preeclampsia would be greater than levels in women with normal pregnancies. Placental extracts were prepared from placental villous biopsies from preeclamptic (n=27) and control (n=43) placentas. EDTA plasma samples were obtained from gestationally age-matched preeclamptic and control normal pregnancies. MPO concentrations were measured by ELISA. Immunohistochemistry was used to determine MPO localization in the placenta. MPO levels in placental extracts from women with preeclampsia were significantly higher than the levels in normal control subjects (546±62 versus 347±32 ng/mL; P=0.025). MPO was found in the floating villi and basal plate of placentas with a greater staining in the basal plates from preeclampsia placentas compared with normal pregnancies. Plasma MPO levels were 3-fold higher in patients with preeclampsia compared with normal control subjects (36.6±7.6 versus 11.0±3.1 ng/mL; P=0.003). In conclusion, MPO levels are significantly increased in the circulation and placenta of women with preeclampsia. We speculate that MPO may contribute to the oxidative damage reported in the endothelium and placenta of women with preeclampsia.
    • File Description:
      text
    • Author Affiliations:
      Magee Womens Research Institute, Pittsburgh, Pa, United States
      Department of Environmental and Occupational Health, University of Pittsburgh, Pa, United States
      Cell and Tissue Biology University of California, San Francisco, United States
      Department of Epidemiology, University of Pittsburgh, Pa, United States
      Department of Dental Public Health and Information Management, University of Pittsburgh, Pa, United States
      Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh, Pa, United States
    • ISSN:
      0194-911X
    • Rights:
      Copyright 2008 INIST-CNRS
      CC BY 4.0
      Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
    • Notes:
      Cardiology. Circulatory system

      Pharmacological treatments
    • Accession Number:
      edscal.20535822